Signaling pathway for zinc prevention of atherosclerosis in monocytes/macrophages and vascular endothelial cells: a proposed hypothesis
Signaling pathway for zinc prevention of atherosclerosis in monocytes/macrophages and vascular endothelial cells: a proposed hypothesis. Reactive oxygen species (ROS) induced by many stimuli modif LDL into oxidized LDL (oxLDL) in macrophages and vascular endothelial cells. oxLDL or ROS can activate the apoptotic pathway via activation of proapoptotic enzymes and the nuclear transcription factor κB (NF-κB) pathway via NF-κB inducible kinase (NIK) activation, which eventually results in the development and progression of atherosclerosis. Zinc might have an atheroprotective function by the following mechanisms: 1) inhibition of ROS generation via metallothionein (MT), superoxide dismutase (SOD), and NADPH, and 2) down-regulation of atherosclerotic cytokines/molecules such as inflammatory cytokines, adhesion molecules, inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX2), fibrinogen, and tissue factor (TF) through inhibition of NF-κB activation by A20-mediating tumor necrosis factor (TNF)–receptor associated factor (TRAF) signaling and peroxisome proliferator–activated receptor α (PPAR-α)–mediating crosstalk signaling. The black arrows indicate up-regulation; arrows with a broken line indicate down-regulation or the inhibitory pathway. IKK, IκB kinase; IL, interleukin; MCP-1, macrophage chemoattractant protein 1; CRP, C-reactive protein; ICAM-1, intercell adhesion molecule 1; VCAM-1, vascular cell adhesion molecule 1.
Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. (2010)
Bin Bao, et al. Am J Clin Nutr. 2010 Jun;91(6):1634-1641. Figure: F3.